Therapeutic Asset Ratings
152 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Durvalumab
Fibrolamellar Hepatocellular Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P1/2
CCC
(48)
lutetium (<sup>177</sup>Lu) zadavotide guraxetan
Nonpapillary Renal Cell Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P1/2
CCC
(48)
Nivolumab
Childhood Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P1/2
CCC
(48)
Itacitinib
Myelodysplastic Syndrome
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
CC
(47)
Belzutifan
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
CC
(46)
BMS 986253
Pancreatic Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
CC
(46)
Fianlimab
Colorectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
CC
(46)
Galunisertib
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
CC
(46)
Polyiclc
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P1/2
CC
(46)
Balstilimab
Pancreatic Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P1/2
CC
(45)
Decitabine
Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P1/2
CC
(45)
lutetium (<sup>177</sup>Lu) zadavotide guraxetan
Renal Cell Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P1/2
CC
(45)
NC 410
Pancreatic Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
CC
(44)
Urelumab
Pancreatic Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
CC
(43)
111in-xyimsr-01
Renal Cell Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P1
CC
(43)
Dnajb1-Prkaca Peptide Vaccine
Fibrolamellar Hepatocellular Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P1
CC
(43)
Ipilimumab
Fibrolamellar Hepatocellular Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P1
CC
(43)
Kras Peptide Vaccine
High Risk Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P1
CC
(43)
Polyiclc
Fibrolamellar Hepatocellular Carcinoma (FLC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P1
CC
(43)
[18F]DK222
Urothelial Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P1
CC
(41)
Itacitinib
Chronic Myeloid Leukemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P1
CC
(41)
Itacitinib
Acute Leukemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P1
CC
(41)
Itacitinib
T-Cell Prolymphocytic Leukemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P1
CC
(41)
Donor T Cells
Myelodysplastic Syndrome
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
CC
(40)
Agen2373
Pancreatic Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P1/2
CC
(40)
Showing 101 to 125 of 152 assets
Previous
Page 5 of 7
Next